Biopharmaceutical manufacturers are beginning to adopt the tools and techniques already used in other high-value sectors, such as semiconductors and electronics, to increase process capability and reliability. Increasingly, digital models are employed to predict quality, identify abnormalities and control the process more effectively.
Model development is constantly evolving, as new data becomes available. It is vital to exploit these models for more than just real time release. Their management - as well as their development - should focus on deriving maximum process knowledge, to help drive process improvement.
To support this next phase of manufacturing intelligence, Perceptive Engineering has released BioAPC®, a purpose-built platform for biopharma.